LOPRAZOLAM Tablets Ref.[9823] Active ingredients: Loprazolam

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: Zentiva Pharma UK Limited, 12 New Fetter Lane, London, EC4A 1JP, United Kingdom

Therapeutic indications

Loprazolam is indicated for the short-term treatment of insomnia including difficulty in falling asleep and/or frequent nocturnal awakenings. Benzodiazepines should be used to treat insomnia only when it is severe, disabling or subjecting the individual to extreme distress. An underlying cause of insomnia should be sought before deciding upon the use of benzodiazepines for symptomatic relief.

Posology and method of administration

Adults

The recommended dose is 1mg at bedtime. This may be increased to 1.5mg or 2mg if necessary.

Elderly

Dosage in the elderly should be limited to 1mg at bedtime.

Frail, debilitated or aged patients

A starting dose of a half tablet may be appropriate. Dosage should not exceed 1mg.

Treatment should if possible be intermittent.

The lowest dose to control symptoms should be used. Treatment should not normally be continued beyond 4 weeks.

Long term chronic use is not recommended.

Treatment should always be tapered off gradually.

Patients who have taken benzodiazepines for a long time may require a longer period during which doses are reduced.

Children

There is insufficient evidence to recommend the use of Loprazolam in children.

Overdose

As with other benzodiazepines, overdosage does not usually present a threat to life. Treatment is symptomatic and gastric lavage may be of use if performed shortly after ingestion. Use of a specific antidote such as flumazenil in association with symptomatic treatment in hospital should be considered.

Shelf life

Shelf life: 24 months.

Special precautions for storage

Store below 25°C in a dry place. Protect from light.

Nature and contents of container

UPVC/aluminium foil blisters, packaged in cartons of 10, 28 or 30 tablets.

Special precautions for disposal and other handling

Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.